To underpin our commitment to serve patients, Amgen is hiring in the department of Medicinal Chemistry at our Research and Development facilities in Cambridge MA (AMA).
The Scientist will be part of a Medicinal Chemistry group.
Conducting laboratory experiments; designing and implementing scientific research; planning detailed procedures for defined projects including timelines, milestones, methodological approaches, expected results and necessary resources; reviewing, analyzing, and interpreting scientific data and results; providing regular updates, documentation, and/or communication on project results; collaborating with other scientists and keeping current with field of expertise, including literature and technology development.
Advising supervisors and colleagues in areas of expertise; participating in national and international scientific meetings; providing scientific results that support the generation of publications, patents, or regulatory submissions and supervising research associates and laboratory assistants.
Master's degree & 4 years of scientific experience
Bachelor's degree & 6 years of scientific experience
Chemistry degree specializing in organic synthesis
Proven track record of academic accomplishments (i.e., peer-reviewed publications and/or patents)
Demonstration of good lab practices, with particular attention to safety
Clear understanding of structural determination using NMR and Mass Spectral techniques as well as knowledge of related purification methods
Understanding of biological and pharmaceutical principles and a working knowledge of the use of structure-based or other computer-aided drug design tools
Knowledge of the application of parallel synthesis techniques to medicinal chemistry
Excellent communication skills (both written and oral)
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.